Genomes and Genes

Species

John Black

Summary

Affiliation: Mayo Clinic
Country: USA

Publications

  1. Ji Y, Skierka J, Blommel J, Moore B, VanCuyk D, Bruflat J, et al. Preemptive Pharmacogenomic Testing for Precision Medicine: A Comprehensive Analysis of Five Actionable Pharmacogenomic Genes Using Next-Generation DNA Sequencing and a Customized CYP2D6 Genotyping Cascade. J Mol Diagn. 2016;18:438-445 pubmed publisher
    ..Our study provides evidence in favor of preemptive PGx testing by identifying the risk of a variant being present in the population we studied. ..
  2. Black J, Silber M, Krahn L, Avula R, Walker D, Pankratz V, et al. Studies of humoral immunity to preprohypocretin in human leukocyte antigen DQB1*0602-positive narcoleptic subjects with cataplexy. Biol Psychiatry. 2005;58:504-9 pubmed
    ..The hypothesis that DQB1*0602-positive narcoleptic subjects with cataplexy have IgG reactive to preprohypocretin or its cleavage products was not supported. ..

Detail Information

Publications2

  1. Ji Y, Skierka J, Blommel J, Moore B, VanCuyk D, Bruflat J, et al. Preemptive Pharmacogenomic Testing for Precision Medicine: A Comprehensive Analysis of Five Actionable Pharmacogenomic Genes Using Next-Generation DNA Sequencing and a Customized CYP2D6 Genotyping Cascade. J Mol Diagn. 2016;18:438-445 pubmed publisher
    ..Our study provides evidence in favor of preemptive PGx testing by identifying the risk of a variant being present in the population we studied. ..
  2. Black J, Silber M, Krahn L, Avula R, Walker D, Pankratz V, et al. Studies of humoral immunity to preprohypocretin in human leukocyte antigen DQB1*0602-positive narcoleptic subjects with cataplexy. Biol Psychiatry. 2005;58:504-9 pubmed
    ..The hypothesis that DQB1*0602-positive narcoleptic subjects with cataplexy have IgG reactive to preprohypocretin or its cleavage products was not supported. ..